These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 20807854)
1. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies. Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854 [TBL] [Abstract][Full Text] [Related]
2. [18F-FDG PET/CT with retrograde filling of the urinary bladder in the assessment of malignant pelvic disease]. García Vicente AM; Núñez García A; Palomar Muñoz A; Pilkington Woll JP; Bellón Guardia ME; González García B; Soriano Castrejón A Rev Esp Med Nucl; 2011; 30(2):71-6. PubMed ID: 21334772 [TBL] [Abstract][Full Text] [Related]
3. Unexpected accumulation of F-18 FDG in the urinary bladder after bladder irrigation and retrograde filling with sterile saline: a possible pitfall in PET examination. Lin WY; Wang KB; Tsai SC; Sun SS Clin Nucl Med; 2009 Sep; 34(9):560-3. PubMed ID: 19692813 [TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer. Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965 [TBL] [Abstract][Full Text] [Related]
5. Detection of recurrence in patients with rectal cancer: PET/CT after abdominoperineal or anterior resection. Even-Sapir E; Parag Y; Lerman H; Gutman M; Levine C; Rabau M; Figer A; Metser U Radiology; 2004 Sep; 232(3):815-22. PubMed ID: 15273334 [TBL] [Abstract][Full Text] [Related]
6. Is whole-body fluorine-18 fluorodeoxyglucose PET/CT plus additional pelvic images (oral hydration-voiding-refilling) useful for detecting recurrent bladder cancer? Yang Z; Cheng J; Pan L; Hu S; Xu J; Zhang Y; Wang M; Zhang J; Ye D; Zhang Y Ann Nucl Med; 2012 Aug; 26(7):571-7. PubMed ID: 22763630 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of 18F-FDG PET with bladder irrigation in patients with uterine and ovarian tumors. Koyama K; Okamura T; Kawabe J; Ozawa N; Torii K; Umesaki N; Miyama M; Ochi H; Yamada R J Nucl Med; 2003 Mar; 44(3):353-8. PubMed ID: 12621000 [TBL] [Abstract][Full Text] [Related]
8. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population. Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346 [TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients. Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003 [TBL] [Abstract][Full Text] [Related]
10. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases]. Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458 [TBL] [Abstract][Full Text] [Related]
11. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer. Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. Ben-Haim S; Kupzov E; Tamir A; Israel O J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049 [TBL] [Abstract][Full Text] [Related]
13. Diuretic 18F-FDG PET/CT imaging for detection and locoregional staging of urinary bladder cancer: prospective evaluation of a novel technique. Nayak B; Dogra PN; Naswa N; Kumar R Eur J Nucl Med Mol Imaging; 2013 Feb; 40(3):386-93. PubMed ID: 23179944 [TBL] [Abstract][Full Text] [Related]
14. Does hyperglycemia affect the diagnostic value of 18F-FDG PET/CT? Mirpour S; Meteesatien P; Khandani AH Rev Esp Med Nucl Imagen Mol; 2012; 31(2):71-7. PubMed ID: 22088805 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of diffusion-weighted imaging in simultaneous 18F-FDG PET/MR imaging for whole-body staging of women with pelvic malignancies. Grueneisen J; Schaarschmidt BM; Beiderwellen K; Schulze-Hagen A; Heubner M; Kinner S; Forsting M; Lauenstein T; Ruhlmann V; Umutlu L J Nucl Med; 2014 Dec; 55(12):1930-5. PubMed ID: 25453042 [TBL] [Abstract][Full Text] [Related]
16. [Value of dual-phase (18)F-FDG PET/CT in preoperative staging of bladder cancer]. Li H; Wu H; Wang Q; Han Y; Wang Q Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):500-3. PubMed ID: 24752096 [TBL] [Abstract][Full Text] [Related]
17. Clinical impact of "true whole-body" (18)F-FDG PET/CT: lesion frequency and added benefit in distal lower extremities. Kawata S; Imaizumi M; Kako Y; Oku N Ann Nucl Med; 2014 May; 28(4):322-8. PubMed ID: 24488705 [TBL] [Abstract][Full Text] [Related]